All Articles tagged Oman

• Oncology
  July 18, 2024 EDT
  Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf Countries
  Anas HamadShereen ElazzazyRuba Y. TahaHani OsmanSana AlblooshiIslam ElkonaissiMustaqeem A. SiddiquiKhalil Al-FarsiMohammed Al LamkiSali EmaraGihan H. Elsisi

  The financial effects of subcutaneous daratumumab vs intravenous daratumumab for treatment of newly diagnosed multiple myeloma in Qatar, Oman and the United Arab Emirates was assessed using a cost-minimization model.

  Abstract